Patellar Tendinopathy. Patellar tendinitis, unspecified knee
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants between 18 to 60 years of age Clinical diagnosis of patellar tendinopathy, confirmed by a qualified healthcare professional Individuals Experiencing chronic patellar tendinopathy symptoms for at least 3 months Moderate severity of symptoms No active inflammatory conditions (e.g., rheumatoid arthritis) or uncontrolled systemic diseases that might affect tendon healing or the safety of treatments.
Exclusion criteria
Exclusion criteria: Individuals with acute (less than 3 months) patellar tendinopathy or other acute knee injuries. Participants with other significant knee conditions (e.g., patellofemoral pain syndrome, osteoarthritis, ligament injuries, or meniscal tears) that may confound the outcomes or interact with the treatments being tested Those who have undergone surgical interventions involving the patellar tendon or knee in the past 6 months. Individuals with uncontrolled systemic diseases, including rheumatoid arthritis, diabetes mellitus, or severe cardiovascular or neurological conditions that could affect tendon healing or physical activity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before interventions and 8 weeks after intervention. Method of measurement: Numerical Pain rating scale and Western Ontario and McMaster Universities Osteoarthritis Index.;Knee range of motion (ROM). Timepoint: Before interventions and 8 weeks after intervention. Method of measurement: Goniometer.;Tendon thickness. Timepoint: Before interventions and 8 weeks after intervention. Method of measurement: ultrasound.;Tendon function. Timepoint: Before interventions and 8 weeks after intervention. Method of measurement: Victorian Institute of Sport Assessment-Achilles (VISA-A). | — |
Secondary
| Measure | Time frame |
|---|---|
| Muscle Strength. Timepoint: Before interventions and 8 weeks after intervention. Method of measurement: Hand dynamometer.;Erythrocyte sedimentation rate (ESR). Timepoint: Before interventions and 8 weeks after intervention. Method of measurement: Lab test.;Quality of life. Timepoint: Before interventions and 8 weeks after intervention. Method of measurement: SF-36 scale.;C-Reactive proteins. Timepoint: Before interventions and 8 weeks after intervention. Method of measurement: Lab test. | — |
Countries
Pakistan
Contacts
Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan.